Alpha-2 macroglobulin is genetically associated with Alzheimer disease
- 1 August 1998
- journal article
- letter
- Published by Springer Science and Business Media LLC in Nature Genetics
- Vol. 19 (4), 357-360
- https://doi.org/10.1038/1243
Abstract
Alpha-2-macroglobulin (α-2M; encoded by the gene A2M) is a serum pan-protease inhibitor that has been implicated in Alzheimer disease (AD) based on its ability to mediate the clearance and degradation of Aß, the major component of ß-amyloid deposits. Analysis of a deletion in the A2M gene at the 5' splice site of 'exon II' of the bait region (exon 18) revealed that inheritance of the deletion (A2M-2 ) confers increased risk for AD (Mantel-Haenzel odds ratio = 3.56, P = 0.001). The sibship disequilibrium test (SDT) also revealed a significant association between A2M and AD (P = 0.00009). These values were comparable to those obtained for the APOE-ε4 allele in the same sample, but in contrast to APOE-ε4, A2M-2 did not affect age of onset. The observed association of A2M with AD did not appear to account for the previously published linkage of AD to chromosome 12, which we were unable to confirm in this sample. A2M, LRP1 (encoding the α-2M receptor) and the genes for two other LRP ligands, APOE and APP (encoding the amyloid ß-protein precursor), have now all been genetically linked to AD, suggesting that these proteins may participate in a common neuropathogenic pathway leading to AD.Keywords
This publication has 26 references indexed in Scilit:
- α 2 -macroglobulin associates with β-amyloid peptide and prevents fibril formationProceedings of the National Academy of Sciences of the United States of America, 1998
- The Genetics of Alzheimer DiseaseArchives of Neurology, 1998
- Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer DiseaseJAMA, 1997
- α2‐Macroglobulin as a β‐Amyloid Peptide‐Binding Plasma ProteinJournal of Neurochemistry, 1997
- Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), and apolipoprotein E receptor, with late-onset Alzheimer's diseaseNeurology, 1997
- ApoE-4 and Age at Onset of Alzheimer's DiseaseNeurology, 1997
- LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradationCell, 1995
- Multiple, diverse senile plaque–associated proteins are ligands of an apolipoprotein e receptor, the α2‐macroglobulin receptor/low‐density‐lipoprotein receptor—related proteinAnnals of Neurology, 1995
- Expression of α2‐macroglobulin receptor/low density lipoprotein receptor‐related protein is increased in reactive and neoplastic glial cellsFEBS Letters, 1994
- Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.Proceedings of the National Academy of Sciences of the United States of America, 1993